Cargando…
A Rare Case of Drug-Induced Liver Injury Caused by Levetiracetam
Levetiracetam (LEV) is one of the newest antiepileptic drugs available on the market and is frequently used in neurosurgical patients requiring antiepileptic assistance. LEV is mainly excreted by the kidney with minimal hepatic metabolism, so it is considered to have a low liver toxicity. Drug-induc...
Autores principales: | Kawaguchi, Tomohiro, Tominaga, Teiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703052/ https://www.ncbi.nlm.nih.gov/pubmed/31497118 http://dx.doi.org/10.4103/ajns.AJNS_246_17 |
Ejemplares similares
-
Severe drug-induced liver injury caused by levetiracetam – A case report and review of the literature
por: Rogalewski, Andreas, et al.
Publicado: (2021) -
Levetiracetam induced psoriasiform drug eruption: a rare case report
por: Gencler, Onur Serdar, et al.
Publicado: (2015) -
Grossly calcified choroid plexus concealing foramen of Monro meningiomas as an unusual cause of obstructive hydrocephalus
por: Kawaguchi, Tomohiro, et al.
Publicado: (2016) -
Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series
por: Kawaguchi, Tomohiro, et al.
Publicado: (2019) -
Levetiracetam Liver Injury: A Benign Antiepileptic Agent?
por: Hegazy, Yassmin, et al.
Publicado: (2023)